# Comparison of Whole Body DWI to FDG PET

> **NCT06630845** · NA · RECRUITING · sponsor: **University of California, San Francisco** · enrollment: 30 (estimated)

## Conditions studied

- Metastatic Cancer

## Interventions

- **DRUG:** Fluorodeoxyglucose F18
- **PROCEDURE:** Positron Emission Tomography combined with Magnetic resonance imaging (PET/MRI)
- **PROCEDURE:** Whole Body Magnetic Resonance Imaging with Diffusion-Weighted Imaging (WB-MRI-DWI)
- **DEVICE:** General Electric (GE) SIGNA PET/MR

## Key facts

- **NCT ID:** NCT06630845
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-06
- **Primary completion:** 2027-10-31
- **Final completion:** 2029-10-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-04-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06630845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06630845, "Comparison of Whole Body DWI to FDG PET". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06630845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*